Podcast
Questions and Answers
Which arteries are primarily affected by peripheral vascular disease (PVD)?
Which arteries are primarily affected by peripheral vascular disease (PVD)?
- Subclavian and carotid arteries
- Pulmonary and jugular veins
- Coronary and cerebral arteries
- Arteries of the lower limbs and renal arteries (correct)
What is the most important risk factor for developing peripheral vascular disease?
What is the most important risk factor for developing peripheral vascular disease?
- Family history of cardiovascular disease
- Age greater than 65 years
- Obesity
- Smoking (correct)
Which of the following is NOT a manifestation of peripheral vascular disease?
Which of the following is NOT a manifestation of peripheral vascular disease?
- Ischemic ulcers
- Palpitations in the chest (correct)
- Intermittent claudication
- Rest pain when elevated
What lifestyle change is identified as the most crucial for managing peripheral vascular disease?
What lifestyle change is identified as the most crucial for managing peripheral vascular disease?
Patients over what age are particularly at risk for developing peripheral vascular disease?
Patients over what age are particularly at risk for developing peripheral vascular disease?
Which treatment is recommended for managing hypercholesterolemia in peripheral vascular disease?
Which treatment is recommended for managing hypercholesterolemia in peripheral vascular disease?
Which symptom commonly presents with intermittent claudication in peripheral vascular disease?
Which symptom commonly presents with intermittent claudication in peripheral vascular disease?
What is a common skin manifestation noticed in patients with peripheral vascular disease?
What is a common skin manifestation noticed in patients with peripheral vascular disease?
What is the primary initial target for systolic blood pressure reduction in the first 1-2 hours during the management of hypertensive emergencies?
What is the primary initial target for systolic blood pressure reduction in the first 1-2 hours during the management of hypertensive emergencies?
Which of the following drugs is NOT recommended for use in the management of hypertensive emergencies?
Which of the following drugs is NOT recommended for use in the management of hypertensive emergencies?
Which of these conditions is associated with hypertensive emergencies and may result from untreated severe hypertension?
Which of these conditions is associated with hypertensive emergencies and may result from untreated severe hypertension?
What should be the approach to lowering blood pressure in hypertensive emergencies to avoid ischemic events?
What should be the approach to lowering blood pressure in hypertensive emergencies to avoid ischemic events?
What is indicated in the management of hypertensive emergencies to prevent significant volume depletion?
What is indicated in the management of hypertensive emergencies to prevent significant volume depletion?
Which symptom is NOT typically associated with hypertensive encephalopathy?
Which symptom is NOT typically associated with hypertensive encephalopathy?
What might occur if blood pressure is lowered too quickly in patients with chronic hypertension?
What might occur if blood pressure is lowered too quickly in patients with chronic hypertension?
Which clinical presentation is characteristic of hypertensive encephalopathy?
Which clinical presentation is characteristic of hypertensive encephalopathy?
What is the primary mechanism of action for pentoxifylline?
What is the primary mechanism of action for pentoxifylline?
Which condition is pentoxifylline NOT primarily indicated for?
Which condition is pentoxifylline NOT primarily indicated for?
What is the typical dosage regimen for pentoxifylline?
What is the typical dosage regimen for pentoxifylline?
Which side effect is most commonly associated with cilostazol?
Which side effect is most commonly associated with cilostazol?
Cilostazol is contraindicated in patients with which condition due to increased mortality risk?
Cilostazol is contraindicated in patients with which condition due to increased mortality risk?
What significant benefit does clopidogrel offer over aspirin in diabetic patients?
What significant benefit does clopidogrel offer over aspirin in diabetic patients?
Which enzyme does cilostazol inhibit?
Which enzyme does cilostazol inhibit?
What effect does pentoxifylline have on blood viscosity?
What effect does pentoxifylline have on blood viscosity?
Pentoxifylline is the second drug approved for treating intermittent claudication.
Pentoxifylline is the second drug approved for treating intermittent claudication.
Peripheral vascular disease (PVD) can affect arteries of the lower limbs, renal, and mesenteric vessels.
Peripheral vascular disease (PVD) can affect arteries of the lower limbs, renal, and mesenteric vessels.
Cilostazol increases platelet aggregation by inhibiting PDE type 3.
Cilostazol increases platelet aggregation by inhibiting PDE type 3.
Hypertension is considered a minor risk factor for developing peripheral vascular disease.
Hypertension is considered a minor risk factor for developing peripheral vascular disease.
Headache is reported as a common side effect of pentoxifylline.
Headache is reported as a common side effect of pentoxifylline.
Intermittent claudication is characterized by muscle pain that occurs during resting.
Intermittent claudication is characterized by muscle pain that occurs during resting.
Skin symptoms associated with peripheral vascular disease can include coolness and bluish discoloration.
Skin symptoms associated with peripheral vascular disease can include coolness and bluish discoloration.
Clopidogrel is an anticoagulant that is preferred over aspirin for patients without diabetes.
Clopidogrel is an anticoagulant that is preferred over aspirin for patients without diabetes.
Cilostazol has a contraindication for use in patients with congestive heart failure (CHF).
Cilostazol has a contraindication for use in patients with congestive heart failure (CHF).
Smoking cessation is considered a crucial lifestyle change for managing peripheral vascular disease.
Smoking cessation is considered a crucial lifestyle change for managing peripheral vascular disease.
The typical dosage for pentoxifylline is 100 mg twice a day.
The typical dosage for pentoxifylline is 100 mg twice a day.
Diabetes and smoking are irrelevant risk factors for developing peripheral vascular disease.
Diabetes and smoking are irrelevant risk factors for developing peripheral vascular disease.
Pentoxifylline decreases the deformability of red blood cells (RBCs) by inhibiting the PDE enzyme.
Pentoxifylline decreases the deformability of red blood cells (RBCs) by inhibiting the PDE enzyme.
Age over 65 years increases the likelihood of peripheral vascular disease.
Age over 65 years increases the likelihood of peripheral vascular disease.
Clopidogrel is less effective than aspirin in reducing vascular events in diabetic patients with peripheral vascular disease.
Clopidogrel is less effective than aspirin in reducing vascular events in diabetic patients with peripheral vascular disease.
Management of hypercholesterolemia in peripheral vascular disease typically involves the use of nitrates.
Management of hypercholesterolemia in peripheral vascular disease typically involves the use of nitrates.
Hypertensive emergencies are defined by a blood pressure greater than 160/100 mmHg.
Hypertensive emergencies are defined by a blood pressure greater than 160/100 mmHg.
One of the initial targets in hypertensive emergencies is to lower systolic blood pressure by no more than 20% in the first 1-2 hours.
One of the initial targets in hypertensive emergencies is to lower systolic blood pressure by no more than 20% in the first 1-2 hours.
Drugs such as sodium nitroprusside and labetalol are considered standard treatment in managing hypertensive emergencies.
Drugs such as sodium nitroprusside and labetalol are considered standard treatment in managing hypertensive emergencies.
Severe headache, mental confusion, and blurred vision are all symptoms associated with hypertensive encephalopathy.
Severe headache, mental confusion, and blurred vision are all symptoms associated with hypertensive encephalopathy.
Furosemide is recommended for everyone managing hypertensive emergencies regardless of volume status.
Furosemide is recommended for everyone managing hypertensive emergencies regardless of volume status.
Nifedipine is a recommended drug for rapid management of hypertensive emergencies.
Nifedipine is a recommended drug for rapid management of hypertensive emergencies.
Cerebral, renal, and myocardial ischemic events can develop if blood pressure is lowered too quickly in chronic hypertension.
Cerebral, renal, and myocardial ischemic events can develop if blood pressure is lowered too quickly in chronic hypertension.
Hypertensive emergencies can result in aortic disentanglement if not treated promptly.
Hypertensive emergencies can result in aortic disentanglement if not treated promptly.
What is the primary action of pentoxifylline on red blood cells (RBCs)?
What is the primary action of pentoxifylline on red blood cells (RBCs)?
For which conditions is pentoxifylline indicated in treatment?
For which conditions is pentoxifylline indicated in treatment?
Which specific PDE enzyme does cilostazol inhibit?
Which specific PDE enzyme does cilostazol inhibit?
What is the typical dosage of cilostazol recommended for patients?
What is the typical dosage of cilostazol recommended for patients?
Which serious condition is cilostazol contraindicated for, and why?
Which serious condition is cilostazol contraindicated for, and why?
What advantage does clopidogrel have over aspirin in patients with diabetic PVD?
What advantage does clopidogrel have over aspirin in patients with diabetic PVD?
How does pentoxifylline impact blood viscosity?
How does pentoxifylline impact blood viscosity?
What is the most common side effect associated with cilostazol?
What is the most common side effect associated with cilostazol?
What anatomical regions can be primarily affected by peripheral vascular disease?
What anatomical regions can be primarily affected by peripheral vascular disease?
Identify two key risk factors for peripheral vascular disease that are modifiable.
Identify two key risk factors for peripheral vascular disease that are modifiable.
What is the main symptom associated with intermittent claudication?
What is the main symptom associated with intermittent claudication?
How does the skin typically present in patients with peripheral vascular disease?
How does the skin typically present in patients with peripheral vascular disease?
What lifestyle intervention is deemed the most important for managing peripheral vascular disease?
What lifestyle intervention is deemed the most important for managing peripheral vascular disease?
At what age do individuals typically begin to see increased risk of peripheral vascular disease?
At what age do individuals typically begin to see increased risk of peripheral vascular disease?
What treatment is generally recommended for patients with hypercholesterolemia as part of peripheral vascular disease management?
What treatment is generally recommended for patients with hypercholesterolemia as part of peripheral vascular disease management?
Name a characteristic symptom that occurs at rest in patients with advanced peripheral vascular disease.
Name a characteristic symptom that occurs at rest in patients with advanced peripheral vascular disease.
What are the potential consequences of rapidly lowering blood pressure in patients with chronic hypertension?
What are the potential consequences of rapidly lowering blood pressure in patients with chronic hypertension?
Explain the significance of the diastolic blood pressure target during the management of hypertensive emergencies.
Explain the significance of the diastolic blood pressure target during the management of hypertensive emergencies.
List two drugs that are not recommended for managing hypertensive emergencies and explain why.
List two drugs that are not recommended for managing hypertensive emergencies and explain why.
What clinical presentation indicates hypertensive encephalopathy, and what may happen if left untreated?
What clinical presentation indicates hypertensive encephalopathy, and what may happen if left untreated?
What initial target is set for the reduction of systolic blood pressure during the first hours of hypertensive emergencies?
What initial target is set for the reduction of systolic blood pressure during the first hours of hypertensive emergencies?
Why should furosemide only be used in specific situations when managing hypertensive emergencies?
Why should furosemide only be used in specific situations when managing hypertensive emergencies?
Describe how parenteral therapy is administered in hypertensive emergencies and its urgency.
Describe how parenteral therapy is administered in hypertensive emergencies and its urgency.
What is a serious risk associated with sudden drops in blood pressure during treatment of hypertensive emergencies?
What is a serious risk associated with sudden drops in blood pressure during treatment of hypertensive emergencies?
The narrowing of the arteries in peripheral vascular disease primarily affects the arteries of the lower ______.
The narrowing of the arteries in peripheral vascular disease primarily affects the arteries of the lower ______.
Intermittent claudication is characterized by pain in ______ when walking.
Intermittent claudication is characterized by pain in ______ when walking.
The most important risk factors for peripheral vascular disease include diabetes and ______.
The most important risk factors for peripheral vascular disease include diabetes and ______.
Skin symptoms associated with peripheral vascular disease can include coolness and ______ discoloration.
Skin symptoms associated with peripheral vascular disease can include coolness and ______ discoloration.
Patients over the age of ______ years are particularly at risk for developing peripheral vascular disease.
Patients over the age of ______ years are particularly at risk for developing peripheral vascular disease.
Treatment of hypertension and diabetes mellitus is part of the ______ factor control for managing peripheral vascular disease.
Treatment of hypertension and diabetes mellitus is part of the ______ factor control for managing peripheral vascular disease.
Stop smoking is considered the most crucial ______ change for managing peripheral vascular disease.
Stop smoking is considered the most crucial ______ change for managing peripheral vascular disease.
Management of hypercholesterolemia in peripheral vascular disease often involves the use of ______.
Management of hypercholesterolemia in peripheral vascular disease often involves the use of ______.
Pentoxifylline increases RBC deformability by inhibition of the ______ enzyme.
Pentoxifylline increases RBC deformability by inhibition of the ______ enzyme.
Pentoxifylline is the 1st drug approved to improve ______ circulation in patients with intermittent claudication.
Pentoxifylline is the 1st drug approved to improve ______ circulation in patients with intermittent claudication.
Cilostazol is contraindicated in patients with ______ because inhibitors of PDE type 3 increase mortality.
Cilostazol is contraindicated in patients with ______ because inhibitors of PDE type 3 increase mortality.
Clopidogrel offers additional benefits when compared with ______ in diabetic patients with PVD.
Clopidogrel offers additional benefits when compared with ______ in diabetic patients with PVD.
The typical dosage of pentoxifylline is ______ mg twice a day.
The typical dosage of pentoxifylline is ______ mg twice a day.
Cilostazol inhibits PDE enzyme type ______, leading to decreased platelet aggregation.
Cilostazol inhibits PDE enzyme type ______, leading to decreased platelet aggregation.
Headache is the most common ______ effect associated with cilostazol.
Headache is the most common ______ effect associated with cilostazol.
Pentoxifylline reduces blood viscosity and facilitates passage of RBCs through narrow ______.
Pentoxifylline reduces blood viscosity and facilitates passage of RBCs through narrow ______.
Hypertensive emergencies are associated with one or more of the following: BP > ______ mmHg.
Hypertensive emergencies are associated with one or more of the following: BP > ______ mmHg.
The clinical presentation of hypertensive encephalopathy consists of severe headache, mental confusion, blurred vision, and focal ______ signs.
The clinical presentation of hypertensive encephalopathy consists of severe headache, mental confusion, blurred vision, and focal ______ signs.
The initial target in the first 1-2 hours is to lower systolic BP by no more than ______%
The initial target in the first 1-2 hours is to lower systolic BP by no more than ______%
Drugs commonly used include sodium nitroprusside, labetalol, fenoldopam, all given by slow ______ infusion.
Drugs commonly used include sodium nitroprusside, labetalol, fenoldopam, all given by slow ______ infusion.
Treatments such as ______ and hydralazine are not recommended as they can cause severe reductions in BP.
Treatments such as ______ and hydralazine are not recommended as they can cause severe reductions in BP.
Cerebral, renal, and myocardial ischemic events can develop if sudden lowering of BP is done due to autoregulatory changes in ______.
Cerebral, renal, and myocardial ischemic events can develop if sudden lowering of BP is done due to autoregulatory changes in ______.
Hypertensive encephalopathy can progress over a period of ______ to convulsions, coma, and even death if untreated.
Hypertensive encephalopathy can progress over a period of ______ to convulsions, coma, and even death if untreated.
Furosemide should be used only if there is associated volume overload as in the case of pulmonary ______ and acute heart failure.
Furosemide should be used only if there is associated volume overload as in the case of pulmonary ______ and acute heart failure.
Match the following hypertensive emergencies with their associated target organ damage:
Match the following hypertensive emergencies with their associated target organ damage:
Match the medications to their specific usage in the management of hypertensive emergencies:
Match the medications to their specific usage in the management of hypertensive emergencies:
Match the following drugs to their categorization regarding recommendations in hypertensive emergencies:
Match the following drugs to their categorization regarding recommendations in hypertensive emergencies:
Match the symptoms of hypertensive encephalopathy with their descriptions:
Match the symptoms of hypertensive encephalopathy with their descriptions:
Match the phases of blood pressure reduction in hypertensive emergencies with their target goals:
Match the phases of blood pressure reduction in hypertensive emergencies with their target goals:
Match the types of organ damage with their related risk of hypertensive emergencies:
Match the types of organ damage with their related risk of hypertensive emergencies:
Match the management strategies for hypertensive emergencies with their appropriate rationale:
Match the management strategies for hypertensive emergencies with their appropriate rationale:
Match the following management interventions with their potential complications:
Match the following management interventions with their potential complications:
Match the following drugs to their primary mechanism of action:
Match the following drugs to their primary mechanism of action:
Match the drugs with their classification or type:
Match the drugs with their classification or type:
Match the following side effects with their respective drugs:
Match the following side effects with their respective drugs:
Match the conditions with the appropriate drug indicated for treatment:
Match the conditions with the appropriate drug indicated for treatment:
Match each drug with its typical dosage for treating its indicated condition:
Match each drug with its typical dosage for treating its indicated condition:
Match the following contraindications with the associated drug:
Match the following contraindications with the associated drug:
Match the following drugs with their approval sequence for treating intermittent claudication:
Match the following drugs with their approval sequence for treating intermittent claudication:
Match each drug with its type of therapy:
Match each drug with its type of therapy:
Match the following risk factors with their relation to peripheral vascular disease (PVD):
Match the following risk factors with their relation to peripheral vascular disease (PVD):
Match the following symptoms with their description in the context of peripheral vascular disease:
Match the following symptoms with their description in the context of peripheral vascular disease:
Match the following management strategies with their purpose for peripheral vascular disease:
Match the following management strategies with their purpose for peripheral vascular disease:
Match the following arteries with their relationship to peripheral vascular disease:
Match the following arteries with their relationship to peripheral vascular disease:
Match the following management strategies with their respective conditions they address:
Match the following management strategies with their respective conditions they address:
Match the following consequences with their context in peripheral vascular disease:
Match the following consequences with their context in peripheral vascular disease:
Match the following treatments with their intended effects in peripheral vascular disease:
Match the following treatments with their intended effects in peripheral vascular disease:
Match the following lifestyle modifications with their intended impact on peripheral vascular disease:
Match the following lifestyle modifications with their intended impact on peripheral vascular disease:
Study Notes
Management of Hypertensive Emergencies
- Hypertensive emergencies occur when blood pressure exceeds 180/120 mmHg, often accompanied by target organ damage.
- Target organ damage may include cerebral stroke, encephalopathy, heart failure, aortic dissection, or papilledema (optic disc edema).
Hypertensive Encephalopathy
- Characterized by severe headache, mental confusion, blurred vision, and focal neurologic signs.
- If untreated, it can progress to convulsions, coma, and death within 12-48 hours.
Management Protocol
- Immediate hospitalization is essential with parenteral therapy for rapid BP reduction, ideally within hours rather than minutes.
- Sudden drastic BP reduction can lead to ischemic events in the brain, heart, and kidneys due to chronic hypertension-related autoregulation changes.
- Initial goal: reduce systolic BP by no more than 25% in the first 1-2 hours, while maintaining diastolic BP above 100 mmHg.
- Commonly used medications include sodium nitroprusside, labetalol, and fenoldopam, all administered via slow intravenous infusion.
Medications to Avoid
- Nifedipine, nitroglycerin, and hydralazine are contraindicated due to the potential for causing severe and uncontrolled BP reductions.
- Furosemide should only be used if there is volume overload, such as in pulmonary edema or acute heart failure.
Peripheral Vascular Disease (PVD)
- PVD is characterized by the narrowing of arteries other than coronary and cerebral vessels, commonly affecting lower limbs and renal/mesenteric arteries.
Risk Factors
- Major risk factors include diabetes and smoking, along with age over 65, hypercholesterolemia, hypertension, and obesity.
Manifestations
- Intermittent claudication: muscle pain during walking.
- Rest pain in feet, worsening when elevated.
- Skin changes may include coolness, bluish discoloration, and ischemic ulcers.
Management Strategies
- Lifestyle Modifications:
- Smoking cessation is crucial.
- Risk factor control, including statins for hypercholesterolemia and treatment for hypertension and diabetes.
Drug Therapy
-
Pentoxifylline:
- Increases RBC deformability by inhibiting PDE enzyme, reducing blood viscosity, and facilitating RBC passage in ischemic sites.
- Approved for improving microvascular circulation in intermittent claudication, diabetic angiopathy, and chronic leg ulcers. Typical dosage: 400 mg twice daily.
-
Cilostazol:
- Recently approved for intermittent claudication, it inhibits PDE3, reduces platelet aggregation, and causes vasodilation.
- Common side effect is headache and contraindicated in patients with congestive heart failure due to increased mortality risk.
-
Clopidogrel:
- This antiplatelet agent (75 mg daily) provides additional benefits over aspirin for diabetic patients with PVD.
Management of Hypertensive Emergencies
- Hypertensive emergencies occur when blood pressure exceeds 180/120 mmHg, often accompanied by target organ damage.
- Target organ damage may include cerebral stroke, encephalopathy, heart failure, aortic dissection, or papilledema (optic disc edema).
Hypertensive Encephalopathy
- Characterized by severe headache, mental confusion, blurred vision, and focal neurologic signs.
- If untreated, it can progress to convulsions, coma, and death within 12-48 hours.
Management Protocol
- Immediate hospitalization is essential with parenteral therapy for rapid BP reduction, ideally within hours rather than minutes.
- Sudden drastic BP reduction can lead to ischemic events in the brain, heart, and kidneys due to chronic hypertension-related autoregulation changes.
- Initial goal: reduce systolic BP by no more than 25% in the first 1-2 hours, while maintaining diastolic BP above 100 mmHg.
- Commonly used medications include sodium nitroprusside, labetalol, and fenoldopam, all administered via slow intravenous infusion.
Medications to Avoid
- Nifedipine, nitroglycerin, and hydralazine are contraindicated due to the potential for causing severe and uncontrolled BP reductions.
- Furosemide should only be used if there is volume overload, such as in pulmonary edema or acute heart failure.
Peripheral Vascular Disease (PVD)
- PVD is characterized by the narrowing of arteries other than coronary and cerebral vessels, commonly affecting lower limbs and renal/mesenteric arteries.
Risk Factors
- Major risk factors include diabetes and smoking, along with age over 65, hypercholesterolemia, hypertension, and obesity.
Manifestations
- Intermittent claudication: muscle pain during walking.
- Rest pain in feet, worsening when elevated.
- Skin changes may include coolness, bluish discoloration, and ischemic ulcers.
Management Strategies
- Lifestyle Modifications:
- Smoking cessation is crucial.
- Risk factor control, including statins for hypercholesterolemia and treatment for hypertension and diabetes.
Drug Therapy
-
Pentoxifylline:
- Increases RBC deformability by inhibiting PDE enzyme, reducing blood viscosity, and facilitating RBC passage in ischemic sites.
- Approved for improving microvascular circulation in intermittent claudication, diabetic angiopathy, and chronic leg ulcers. Typical dosage: 400 mg twice daily.
-
Cilostazol:
- Recently approved for intermittent claudication, it inhibits PDE3, reduces platelet aggregation, and causes vasodilation.
- Common side effect is headache and contraindicated in patients with congestive heart failure due to increased mortality risk.
-
Clopidogrel:
- This antiplatelet agent (75 mg daily) provides additional benefits over aspirin for diabetic patients with PVD.
Management of Hypertensive Emergencies
- Hypertensive emergencies occur when blood pressure exceeds 180/120 mmHg, often accompanied by target organ damage.
- Target organ damage may include cerebral stroke, encephalopathy, heart failure, aortic dissection, or papilledema (optic disc edema).
Hypertensive Encephalopathy
- Characterized by severe headache, mental confusion, blurred vision, and focal neurologic signs.
- If untreated, it can progress to convulsions, coma, and death within 12-48 hours.
Management Protocol
- Immediate hospitalization is essential with parenteral therapy for rapid BP reduction, ideally within hours rather than minutes.
- Sudden drastic BP reduction can lead to ischemic events in the brain, heart, and kidneys due to chronic hypertension-related autoregulation changes.
- Initial goal: reduce systolic BP by no more than 25% in the first 1-2 hours, while maintaining diastolic BP above 100 mmHg.
- Commonly used medications include sodium nitroprusside, labetalol, and fenoldopam, all administered via slow intravenous infusion.
Medications to Avoid
- Nifedipine, nitroglycerin, and hydralazine are contraindicated due to the potential for causing severe and uncontrolled BP reductions.
- Furosemide should only be used if there is volume overload, such as in pulmonary edema or acute heart failure.
Peripheral Vascular Disease (PVD)
- PVD is characterized by the narrowing of arteries other than coronary and cerebral vessels, commonly affecting lower limbs and renal/mesenteric arteries.
Risk Factors
- Major risk factors include diabetes and smoking, along with age over 65, hypercholesterolemia, hypertension, and obesity.
Manifestations
- Intermittent claudication: muscle pain during walking.
- Rest pain in feet, worsening when elevated.
- Skin changes may include coolness, bluish discoloration, and ischemic ulcers.
Management Strategies
- Lifestyle Modifications:
- Smoking cessation is crucial.
- Risk factor control, including statins for hypercholesterolemia and treatment for hypertension and diabetes.
Drug Therapy
-
Pentoxifylline:
- Increases RBC deformability by inhibiting PDE enzyme, reducing blood viscosity, and facilitating RBC passage in ischemic sites.
- Approved for improving microvascular circulation in intermittent claudication, diabetic angiopathy, and chronic leg ulcers. Typical dosage: 400 mg twice daily.
-
Cilostazol:
- Recently approved for intermittent claudication, it inhibits PDE3, reduces platelet aggregation, and causes vasodilation.
- Common side effect is headache and contraindicated in patients with congestive heart failure due to increased mortality risk.
-
Clopidogrel:
- This antiplatelet agent (75 mg daily) provides additional benefits over aspirin for diabetic patients with PVD.
Management of Hypertensive Emergencies
- Hypertensive emergencies occur when blood pressure exceeds 180/120 mmHg, often accompanied by target organ damage.
- Target organ damage may include cerebral stroke, encephalopathy, heart failure, aortic dissection, or papilledema (optic disc edema).
Hypertensive Encephalopathy
- Characterized by severe headache, mental confusion, blurred vision, and focal neurologic signs.
- If untreated, it can progress to convulsions, coma, and death within 12-48 hours.
Management Protocol
- Immediate hospitalization is essential with parenteral therapy for rapid BP reduction, ideally within hours rather than minutes.
- Sudden drastic BP reduction can lead to ischemic events in the brain, heart, and kidneys due to chronic hypertension-related autoregulation changes.
- Initial goal: reduce systolic BP by no more than 25% in the first 1-2 hours, while maintaining diastolic BP above 100 mmHg.
- Commonly used medications include sodium nitroprusside, labetalol, and fenoldopam, all administered via slow intravenous infusion.
Medications to Avoid
- Nifedipine, nitroglycerin, and hydralazine are contraindicated due to the potential for causing severe and uncontrolled BP reductions.
- Furosemide should only be used if there is volume overload, such as in pulmonary edema or acute heart failure.
Peripheral Vascular Disease (PVD)
- PVD is characterized by the narrowing of arteries other than coronary and cerebral vessels, commonly affecting lower limbs and renal/mesenteric arteries.
Risk Factors
- Major risk factors include diabetes and smoking, along with age over 65, hypercholesterolemia, hypertension, and obesity.
Manifestations
- Intermittent claudication: muscle pain during walking.
- Rest pain in feet, worsening when elevated.
- Skin changes may include coolness, bluish discoloration, and ischemic ulcers.
Management Strategies
- Lifestyle Modifications:
- Smoking cessation is crucial.
- Risk factor control, including statins for hypercholesterolemia and treatment for hypertension and diabetes.
Drug Therapy
-
Pentoxifylline:
- Increases RBC deformability by inhibiting PDE enzyme, reducing blood viscosity, and facilitating RBC passage in ischemic sites.
- Approved for improving microvascular circulation in intermittent claudication, diabetic angiopathy, and chronic leg ulcers. Typical dosage: 400 mg twice daily.
-
Cilostazol:
- Recently approved for intermittent claudication, it inhibits PDE3, reduces platelet aggregation, and causes vasodilation.
- Common side effect is headache and contraindicated in patients with congestive heart failure due to increased mortality risk.
-
Clopidogrel:
- This antiplatelet agent (75 mg daily) provides additional benefits over aspirin for diabetic patients with PVD.
Management of Hypertensive Emergencies
- Hypertensive emergencies occur when blood pressure exceeds 180/120 mmHg, often accompanied by target organ damage.
- Target organ damage may include cerebral stroke, encephalopathy, heart failure, aortic dissection, or papilledema (optic disc edema).
Hypertensive Encephalopathy
- Characterized by severe headache, mental confusion, blurred vision, and focal neurologic signs.
- If untreated, it can progress to convulsions, coma, and death within 12-48 hours.
Management Protocol
- Immediate hospitalization is essential with parenteral therapy for rapid BP reduction, ideally within hours rather than minutes.
- Sudden drastic BP reduction can lead to ischemic events in the brain, heart, and kidneys due to chronic hypertension-related autoregulation changes.
- Initial goal: reduce systolic BP by no more than 25% in the first 1-2 hours, while maintaining diastolic BP above 100 mmHg.
- Commonly used medications include sodium nitroprusside, labetalol, and fenoldopam, all administered via slow intravenous infusion.
Medications to Avoid
- Nifedipine, nitroglycerin, and hydralazine are contraindicated due to the potential for causing severe and uncontrolled BP reductions.
- Furosemide should only be used if there is volume overload, such as in pulmonary edema or acute heart failure.
Peripheral Vascular Disease (PVD)
- PVD is characterized by the narrowing of arteries other than coronary and cerebral vessels, commonly affecting lower limbs and renal/mesenteric arteries.
Risk Factors
- Major risk factors include diabetes and smoking, along with age over 65, hypercholesterolemia, hypertension, and obesity.
Manifestations
- Intermittent claudication: muscle pain during walking.
- Rest pain in feet, worsening when elevated.
- Skin changes may include coolness, bluish discoloration, and ischemic ulcers.
Management Strategies
- Lifestyle Modifications:
- Smoking cessation is crucial.
- Risk factor control, including statins for hypercholesterolemia and treatment for hypertension and diabetes.
Drug Therapy
-
Pentoxifylline:
- Increases RBC deformability by inhibiting PDE enzyme, reducing blood viscosity, and facilitating RBC passage in ischemic sites.
- Approved for improving microvascular circulation in intermittent claudication, diabetic angiopathy, and chronic leg ulcers. Typical dosage: 400 mg twice daily.
-
Cilostazol:
- Recently approved for intermittent claudication, it inhibits PDE3, reduces platelet aggregation, and causes vasodilation.
- Common side effect is headache and contraindicated in patients with congestive heart failure due to increased mortality risk.
-
Clopidogrel:
- This antiplatelet agent (75 mg daily) provides additional benefits over aspirin for diabetic patients with PVD.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers the management and implications of hypertensive emergencies, focusing on the critical condition defined by blood pressure levels exceeding 180/120 mmHg. Special emphasis is placed on recognizing signs of target organ damage such as hypertensive encephalopathy and the associated risks if left untreated.
